Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy

Yakov Chudnovsky, Runjun D. Kumar, Alexa B. Schrock, Caitlin Connelly, Kyle Gowen, Garrett M. Frampton, Rachel L. Erlich, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali, Ron Bose

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalJCO Precision Oncology
Issue number1
StatePublished - 2017

Cite this